Job Watch

Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-22-037 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications focused on advancing development of vaccine candidates against Enterotoxigenic Escherichia coli (ETEC), Salmonella enterica serotype Paratyphi A, and two Shigella species, Shigella flexneri and S. sonnei.

Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed)

Funding Opportunity RFA-HG-22-002 from the NIH Guide for Grants and Contracts. To integrate and disseminate resources for cloud-based education in computational genomics and data science in institutions serving students from underrepresented populations in these topics, and act as a facilitator for faculty in such institutions to create courses in these topics.

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Funding Opportunity PAR-22-105 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. All applications must be within the scope of the mission of one of the Institutes/Centers listed above.

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Funding Opportunity PAR-22-109 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. All applications must be within the scope of the mission of one of the Institutes/Centers listed above.

NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)

Funding Opportunity PAR-22-160 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity announcement is to support meritorious research projects that involve secondary statistical analyses of existing dental, oral or craniofacial database resources, or that develop needed statistical methodology for analyzing existing dental, oral or craniofacial databases.

Notice of Legislative Mandates in Effect for FY 2022

Notice NOT-OD-22-117 from the NIH Guide for Grants and Contracts

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

Funding Opportunity PAR-22-167 from the NIH Guide for Grants and Contracts. The Clinical and Translational Science Award (CTSA) Program Collaborative and Innovative Acceleration Award (CCIA) supports synergistic activities that accelerate the translational research process through collaboration and innovation. This funding opportunity announcement (FOA) invites applications to develop, demonstrate and disseminate innovative solutions to transform the field of translational science by addressing the inefficiencies that are common across diseases and bringing more interventions to all people more quickly through collaborative science among the CTSA Program hubs, NIH Institutes, Centers, Offices (ICOs) and/or external stakeholders.

New Scientist Academy: How to think critically and creatively

New Scientist - Bioinformatics - Mon, 2022-05-09 09:59
Course only £99: New Scientist Academy: Critical thinking and creativity are key skills needed for the increasingly digitalised workplace. New Scientist Academy’s new online course..... Worldwide
Categories: Job Watch

Bioinformatics Analyst II - Medical College of Wisconsin - Milwaukee, WI

Indeed.com - Bioinformatics - Mon, 2022-05-09 05:10
Determines and performs appropriate bioinformatic analysis of data generated through high complexity techniques. Along with Flexible Spending options.
From Medical College of Wisconsin - Mon, 09 May 2022 09:10:33 GMT - View all Milwaukee, WI jobs
Categories: Job Watch

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

Funding Opportunity PAR-22-106 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. All applications must be within the scope of the mission of one of the Institutes/Centers listed above.

Notice of Change to Foreign Component Eligibility in PAR-20-217, PAR-20-218, and PAR-21-240

Notice NOT-AT-22-023 from the NIH Guide for Grants and Contracts

Pages

Subscribe to Anil Jegga aggregator - Job Watch